Aim: The aim of our study was to illustrate the performance of the intraoperative PTH measurement as a predictor of successful cure.
INTRODUCTION
Throughout the nineteen nineties new strategies in the handling of patients with primary hyperparathyroidism (pHPT) have evolved. In spite of an already high rate of success in the operative treatment, new strategies have been developed to improve this rate. In addition to ultrasound, the use of technetium-99m sestaMIBI scintigrafi, MR-and CT-scans have continuously improved the sensitivity of preoperative adenoma localization (1, 2). Parallel to this, there has, at least in some centers, been a change in operating strategy from the bilateral neck exploration with identification of all the parathyroid glands, to a minimal invasive strategy, focusing only on preoperative localized pathologic glands (3-5). In this context, intraoperative determination of intact parathyroid hormone (PTH) seems to be a useful tool for the surgeon (6-9).
Theoretically, an intraoperative decrease in plasma PTH (P-PTH) should be able to predict the outcome of the operation, because PTH has a short halflife of around 3.5 min (10, 11) , mainly due to high liver metabolism (sixty to seventy percent) and rapid kidney excretion (twenty to thirty percent) (12) . Due to this short half life, a continued production of PTH is crucial in the maintenance of an adequate PTH level in the blood. Thus, sufficient operative intervention in pHPT, would cause a rapid drop in P-PTH to the low level of the remaining depressed glands.
The aim of our study was to evaluate the performance of the intraoperative PTH measurement.
MATERIAL AND METHODS

MATERIALS
From September 1999 to April 2002 143 patients underwent a parathyroid operation with intraoperative PTH measurement.
The inclusion criteria were:
• serum calcium (S-Ca) adjusted for albumin >2.70 mmol/l, or S-Ca (mean of 3 values) above normal range (2.20-2.52 mmol/l), and • P-PTH above normal range (1.3-7.6 pmol/l), or P-PTH (mean of 2 values) in the upper third of the normal range, and • no use of thiazide diuretics, loop diuretics, lithium, calcium, or D-vitamin supplements.
The mean age of the patients was 61 years (range; 21-87 years) and 125 patients (87.4 %) were females.
METHODS
All patients had a bilateral neck exploration with the intention to identify all parathyroid glands. The strategy was to resect macroscopically pathologic glands with confirmation of the diagnosis by frozen section. All glands with a macroscopically suspect appearance were biopsied. Serum and urine levels of calcium, phosphate and creatinine were measured by standard laboratory methods. Plasma intact PTH was measured using Immulite Turbo Intact PTH -a double antibody chemiluminiscens immunometric analysis. The total analysis time, including 5 minutes for transportation to the central laboratory, was twenty minutes.
Intraoperative blood samples were taken before intubation of the patient (T0) and exactly 5 minutes after gland excision (T5). Both of the samples were taken from arterial blood using an EDTA containing tube.
A pilot-study was performed in order to set the preliminary limits for a positive and a negative intraoperative test. A positive test was defined as a decrease in the concentration of P-PTH to below 20 % of the T0 or into the normal range below 7.6 pmol/l five minutes after resection of an enlarged parathyroid gland (T5). Hence a negative test result was a sample at T5 with a P-PTH concentration above 7.6 pmol/l and with P-PTH concentration drop of less than 80 % from T0 to T5.
In case the result of the test was positive and the frozen section had shown a pathological gland, the operation was finished. If the result came up negative, usually another PTH measurement was performed while the surgeon continued the search for pathological glands.
The patients had a follow-up examination two months after the operation. Patients with a normal S-Ca value without calcium and/or vitamin D supplementation were considered cured. Persistent hyperparathyroidism was presumed in patients with elevated S-Ca and P-PTH values.
Four follow-up outcomes of the intraoperative PTH test were defined: 1. True positive: the intraoperative PTH test came up positive and the S-Ca was normalised or low. 2. False positive: the intraoperative PTH test came up positive but the S-Ca was still elevated. 3. True negative: the intraoperative PTH measurement came up negative and the hypercalcemia persisted. 4. False negative: the intraoperative PTH measurement came up negative but the S-Ca was normalized.
STATISTICS
Age of the patients was described by mean and range. Intraoperative PTH values at T5 were expressed as absolute values and percent of the initial value at T0.
RESULTS
The results are summarized in Table 1 which consists of four groups:
This main group of patients went through a successful operation with a decrease in P-PTH five minutes after resection of the gland and with normal or low S-Ca values at the follow-up examination. Fig. 1 gives two examples of the intraoperative PTH measurements. This group also included three patients with marginally elevated S-Ca values which all the less were considered cured (se below). These 11 patients were all cured with normalized S-Ca two months after the operation. Nevertheless they did not have the expected intraoperative fall in P-PTH.
-E ight patients nearly fulfilled the success criteria with a intraoperative fall in P-PTH between 73.5 % and 79.5 %. These eight patients included six women and two men, age (median) 60 (range: 42-79 In these 10 cases the result of the primary operation was negative, and P-PTH stayed elevated:
-F ive patients went through a second successful operation after sestaMIBI-scintigrafi had localized the missed adenoma. -F our patients are still followed with reduced but persisting pHPT at the end of the study. -O ne patient of 74 years of age had only few symptoms from hypercalcemia (2.73 mmol/l) and refused further follow-up.
DISCUSSION
The intraoperative PTH assay was introduced by Nussbaum et al. in 1988 (13) , but the application of the procedure in clinical practice has for many years been sporadic. Lately, the development of rapid assays has lead to a more widespread use of the method. Most reports (6-8) have confirmed its validity in determining whether all hyper functioning parathyroid tissue has been removed, although this has been questioned by others (14) . The present study, using a criteria of 80 % decrease of T5, has shown that intraoperative PTH measurement using the Immulite Turbo Intact PTH has a sensitivity of 92 percent and a specificity of 100 percent. These results are competitive. We performed the PTH analysis in our central laboratory contrary to most other studies, where the whole procedure is performed in the operating theater. Nevertheless, the results were available within 20 minutes, a period we consider acceptable for the use of the method in daily surgical practice.
With the half life of P-PTH of 3.4 minutes (10) the fall in P-PTH should theoretically be about 65-70 %. However, after successful removal of an adenoma most of the present patients had a fall in the plasma level of PTH of 80 % or more. Two factors might contribute to this apparent controversy. First, the collection of the blood sample probably often is some sec- 
Test results of intraoperative PTH measurements for 143 patients operated for pHPT. A Test positive case was defined as a decrease in the concentration of PTH to below 20 % of the initial value (T0) or into
the normal range below 7.6 pmol/l five minutes after resection of an enlarged parathyroid gland (T5). Hence a Test negative case was defined as a sample of T5 with a PTH concentration above 7.6 pmol/l and with a fall in PTH concentration less than 80 % from T0 to T5.
Test positive 122( 85) 0 0( 0) 122 0 (85) Test negative 0 11 0 (8) 10 (7) 0 21 0 (15) 133 (93) 10 (7) 143 (100) 1 . Two examples of intraoperative PTH measurements in patients operated for primary hyperparathyroidism. Patient 1 had an adenoma of 840 mg removed and verified by frozen section. Five minutes later the PTH value had dropped from 29.4 pmol/l to 4.6 pmol/l a 84 % decline. Patient 2 had a preoperative sestaMIBI scintigrafi indicating the presence of pathologic tissue in the lower left gland. First, the lower left gland was removed after visualization of normal glands at lower right and upper left position. As shown, this did not lead to a change in the PTH value, and frozen section showed normal tissue. Later, at the upper right position, a 290 mg adenoma was found and removed leading to a 76 % decrease in PTH from 10.5 pmol/l to 2.5 pmol/l. Pre: PTH at the preoperative examination of the patient, T0: PTH in the operating room before the operation, T5: PTH after removal of the first gland, New T5: PTH after removal of the second gland. onds delayed so in fact the T5 value reflects the PTH level somewhere between five and six minutes after removal of the adenoma. Second, the manipulation of the adenoma prior to extirpation probably leads to reduced PTH release from the adenoma in some patients.
In the evaluation of the cut off value we have tried to estimate the consequences of changing it from the present 80 % to 50 %, as used in most other studies. There were, in our study, 47 patients (33 %) with a P-PTH fall above 50 % but less than 80 %. Thirty-four of these were regarded as test positive, as their hormone level dropped to a value in the normal range. Thus, in our study thirteen patients were test negative but would have been test positive, if the cut off value was set at 50 %. These included nine patients cured by the primary procedure (removal of a solitary adenoma in each case). The continued explorations in these patients were negative, and postoperative Ca measurements showed normal values in all cases. Of the remaining four patients, tree patients turned out to have hyperplasia. In each case the primary operation was terminated after removal of one pathological gland, but as the postoperative measurements showed continued disease, a new exploration was performed and further pathological glands were found and removed. Thereafter, all three patients have had normal S-Ca values. The last patient had a 5.2 g cystic adenoma. After adenoma removal, S-Ca dropped from 3.08 to 2.55 mmol/l with continued slightly elevated PTH level. So, if a 50 % cut off value had been used, these four patients would have turned out to be false positive. Thus, lowering the cut off value to 50 % would have increased the sensitivity, as seven more patients would have been true positive, but the price to be paid for that gain would have been 4 false positive results. The consequence of a false positive result in most cases is a new operation at a later time, which is more inconvenient for a patient than the prolongation of the operative procedure following a false negative result.
The development of sensitive preoperative localization studies in pHPT has lead to recommendations from some institutions of unilateral or focused approach or of minimal invasive procedures such as video-assisted or purely endoscopic operations. The potential benefit of such strategies is decreased risk of postoperative complications, shorter operating time, and better cosmetic results. Most surgeons consider intraoperative PTH measurements mandatory in unilateral operations, due to the risk of multiglandular disease (10-15 %) . Bilateral explorations should be performed when removal of a seemingly abnormal parathyroid is not followed by a sufficient P-PTH drop. We had a rather high rate of false negative results (8 %) in this series, and therefore recommend that a new PTH value is measured as soon as the negative result of the first value is known and at the same time as the operative procedure is resumed and the other side explored. These patients will have a prolonged operative time, but as mentioned earlier, this is a minor problem which could further be minimized by lowering the cut off PTH value. Inevitably, though, this would lead to false positive results, which in our opinion, is a much greater problem because the consequences for some patients is persistent disease and need of another operation.
Unexpectedly, our study of patients with hyperparathyroidism revealed three patients with both a parathyroid adenoma and calcium creatinine clearance ratios below 0.01 indicating that these patients suffered from familial hypocalciuric hypercalcemia (FHH). Preoperative urinary calcium values were low (average 1.4 mmol/d). Postoperatively they all had marginally elevated S-Ca values (average 2.64 mmol/l) although substantially lower than the preoperative values (average 3.01 mmol/l). FHH is a harmless condition with lifelong non-progressive hypercalcemia for which there is no treatment. It is an autosomal dominant inherited disease caused by mutations in the calcium sensing receptor (CaSR) gene (15) . Neonatal severe primary hyperparathyroidism reflects homozygous mutations in the gene and is accompanied by parathyroid hyperplasia, but, to our knowledge, the presence of both conditions has only been described in one case in an adult patient (16) , and, as a matter of fact, mutations of the calcium sensing receptor gene seem not to lead to increased risk of parathyroid tumors (17) . Nevertheless, these observations should be kept in mind, and if parathyroidectomy is not followed by normalization of S-Ca, we recommend, that calcium creatinine clearance ratio should be measured, and also the family history should be obtained, and genetic testing of the CaSR gene considered, before new parathyroid exploration is considered.
CONCLUSION
The rapid PTH test used is a reliable predictor of successful cure by parathyroidectomy for primary hyperparathyroidism.
